As law­suit car­ries on against Guardant Health, CFO shake­up hits Il­lu­mi­na; Pfiz­er-backed biotech taps CEO to lead pur­suit of gene ther­a­py 2.0

Sam Samad is out as CFO of Il­lu­mi­na as chief strat­e­gy and cor­po­rate de­vel­op­ment of­fi­cer Joy­deep Goswa­mi slides in for him on an in­ter­im ba­sis start­ing Ju­ly 8. Goswa­mi joined Fran­cis deS­ouza’s crew in 2019 as SVP of cor­po­rate de­vel­op­ment and strate­gic plan­ning af­ter his time as pres­i­dent of Ther­mo Fish­er’s clin­i­cal next-gen­er­a­tion se­quenc­ing (NGS) and on­col­o­gy busi­ness unit.

Guardant Health, a pri­ma­ry liq­uid biop­sy screen­ing test com­peti­tor, filed a mo­tion to dis­miss Il­lu­mi­na’s case against the com­pa­ny in late May. Its co-founders and co-CEOs, Helmy El­toukhy and Ami­rAli Ta­lasaz, are for­mer staffers at Il­lu­mi­na, which is al­leg­ing that the pair in­fringed on in­tel­lec­tu­al prop­er­ty to de­vel­op Guardant’s tech­nol­o­gy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.